Raidel Figueroa, Chief Executive Officer and President As Chief Executive Officer and President of PharmaTech-LLC Mr. Figueroa oversees PharmaTech’s long term organizational goals by converting PharmaTech’s mission statement from a broad vision into specific plans and projects to drive organizational growth and meet current and future customer demands.
Under his leadership, PharmaTech has signed a strategic partnership to acquire a drug delivery platform that enhances bio-availability using nanotechnology, executed multiple generic drug development deals and spearheaded a 10 million dollar solid orals facility expansion to support contract commercial manufacturing operations.
Mr. Figueroa has successfully led the transformation of PharmaTech-LLC from inception into a fully integrated Contract Drug Development and Manufacturing Organization with ANDA commercialization capabilities
Mr. Figueroa also has extensive international and national business development experience and has been instrumental in successful corporate development activities encapsulating financing, product and company acquisitions, in-licensing and company M&A activities.
Mr. Figueroa holds a B.S in Chemistry from Florida International University.